160 related articles for article (PubMed ID: 1495828)
21. Anti-staphylococcal activity of indolmycin, a potential topical agent for control of staphylococcal infections.
Hurdle JG; O'Neill AJ; Chopra I
J Antimicrob Chemother; 2004 Aug; 54(2):549-52. PubMed ID: 15243028
[TBL] [Abstract][Full Text] [Related]
22. [Antibacterial activity of norfloxacin, ofloxacin and ciprofloxacin according to resistance phenotypes to nalidixic acid and pefloxacin].
Soussy CJ; Le Van Thoi J; Duval J
Pathol Biol (Paris); 1990 May; 38(5):376-84. PubMed ID: 2367152
[TBL] [Abstract][Full Text] [Related]
23. High prevalence of resistance to fusidic acid in clinical isolates of Staphylococcus epidermidis.
McLaws F; Chopra I; O'Neill AJ
J Antimicrob Chemother; 2008 May; 61(5):1040-3. PubMed ID: 18299637
[TBL] [Abstract][Full Text] [Related]
24. Fusidic acid as a potential antistaphylococcal agent.
Nicholson J; Chew T; Smith S
N Z Med J; 1999 Jul; 112(1091):261-2. PubMed ID: 10448991
[No Abstract] [Full Text] [Related]
25. [In vitro study of the cefamandole-fosfomycin combination against methicillin-resistant staphylococci].
Fosse T; David MF; Duluc F; Darmusey D; Tamalet C; Toga B
Pathol Biol (Paris); 1984 Jun; 32(5 Pt 2):528-31. PubMed ID: 6462742
[TBL] [Abstract][Full Text] [Related]
26. Fusidic acid alone or in combination with vancomycin for therapy of experimental endocarditis due to methicillin-resistant Staphylococcus aureus.
Fantin B; Leclercq R; Duval J; Carbon C
Antimicrob Agents Chemother; 1993 Nov; 37(11):2466-9. PubMed ID: 8285635
[TBL] [Abstract][Full Text] [Related]
27. Successful oral pristinamycin therapy for osteoarticular infections due to methicillin-resistant Staphylococcus aureus (MRSA) and other Staphylococcus spp.
Ng J; Gosbell IB
J Antimicrob Chemother; 2005 Jun; 55(6):1008-12. PubMed ID: 15845784
[TBL] [Abstract][Full Text] [Related]
28. [Methicillin resistant staphylococci].
Afanas'eva TI
Antibiot Khimioter; 1998; 43(6):29-31. PubMed ID: 9644532
[No Abstract] [Full Text] [Related]
29. In-vitro activity of fusidic acid against methicillin-resistant Staphylococcus aureus.
Erdenizmenli M; Yapar N; Sengönül A; Yüce A; Cakir N; Yulug N
J Chemother; 2004 Jun; 16(3):310-1. PubMed ID: 15330332
[No Abstract] [Full Text] [Related]
30. Fusidic acid resistance in community isolates of methicillin-susceptible Staphylococcus aureus and fusidic acid prescribing.
Mason BW; Howard AJ; Magee JT
J Antimicrob Chemother; 2003 Apr; 51(4):1033-6. PubMed ID: 12654748
[TBL] [Abstract][Full Text] [Related]
31. Fusidic acid for the treatment of bone and joint infections caused by meticillin-resistant Staphylococcus aureus.
Wang JL; Tang HJ; Hsieh PH; Chiu FY; Chen YH; Chang MC; Huang CT; Liu CP; Lau YJ; Hwang KP; Ko WC; Wang CT; Liu CY; Liu CL; Hsueh PR
Int J Antimicrob Agents; 2012 Aug; 40(2):103-7. PubMed ID: 22612900
[TBL] [Abstract][Full Text] [Related]
32. Quality control of direct molecular diagnostics for methicillin-resistant Staphylococcus aureus.
van Belkum A; Niesters HG; MacKay WG; van Leeuwen WB
J Clin Microbiol; 2007 Aug; 45(8):2698-700. PubMed ID: 17581936
[TBL] [Abstract][Full Text] [Related]
33. [The bactericidal power of antibiotic combinations. Application in the treatment of osteo-articular infections due to Staphylococcus aureus (author's transl)].
Sirot J; Lopitaux R; Cluzel R; Bussière JL; Rampon S
Nouv Presse Med; 1978 Oct; 7(36):3217-22. PubMed ID: 733486
[TBL] [Abstract][Full Text] [Related]
34. [Outburst of fusidic acid resistant Staphylococcus aureus].
Kanazaki H; Akiyama H; Kanamoto A; Abe Y; Yamada T; Arata J; Umemura S; Ikeda M
Nihon Hifuka Gakkai Zasshi; 1989 Apr; 99(4):507-10. PubMed ID: 2614994
[TBL] [Abstract][Full Text] [Related]
35. Fusidic acid in bone and joint infections.
Atkins B; Gottlieb T
Int J Antimicrob Agents; 1999 Aug; 12 Suppl 2():S79-93. PubMed ID: 10528790
[TBL] [Abstract][Full Text] [Related]
36. Fusidic acid resistance in Staphylococcus aureus isolates.
Brown EM; Thomas P
Lancet; 2002 Mar; 359(9308):803. PubMed ID: 11888633
[No Abstract] [Full Text] [Related]
37. A fatal infection caused by methicillin-resistant Staphylococcus aureus acquiring resistance to gentamicin and fusidic acid during therapy.
Amirak ID; Li AK; Williams RJ; Noone P
J Infect; 1981 Mar; 3(1):50-8. PubMed ID: 6926536
[No Abstract] [Full Text] [Related]
38. Demonstration of in vitro antagonism between fusidic acid and quinolones.
Ertek M; Yazgi H; Erol S; Altoparlak U
J Int Med Res; 2002; 30(5):525-8. PubMed ID: 12449523
[TBL] [Abstract][Full Text] [Related]
39. Fusidic acid in staphylococcal bone and joint infection.
Coombs RR
J Antimicrob Chemother; 1990 Feb; 25 Suppl B():53-60. PubMed ID: 2179204
[TBL] [Abstract][Full Text] [Related]
40. Fusidic acid resistance in community isolates of methicillin susceptible Staphylococcus aureus and the use of topical fusidic acid: a retrospective case-control study.
Mason BW; Howard AJ
Int J Antimicrob Agents; 2004 Mar; 23(3):300-3. PubMed ID: 15164973
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
